Innovest Global Completes Sale of StemVax Therapeutics to NovAccess Global Innovest Global Receives 7.5 Million Shares of NovAccess Global Common Stock as Consideration for StemVax Therapeutics; …
NovAccess Global Acquires StemVax Therapeutics from Innovest Global Acquisition Launches NovAccess Shift, Focusing on Diagnostics and Therapeutics in Cancer CLEVELAND, OH / ACCESSWIRE / September 9, …